Home  /  Cells  /  Vol: 6 Núm: 4 Par: Decembe (2017)  /  Article
ARTICLE
TITLE

How Can Elispot Add Information to Improve Knowledge on Tropical Diseases?

SUMMARY

Elispot has been used as an important tool for detecting immune cells’ products and functions and has facilitated the understanding of host-pathogen interaction. Despite the incredible diversity of possibilities, two main approaches have been developed: the immunopathogenesis and diagnosis/prognosis of infectious diseases as well as cancer research. Much has been described on the topics of allergy, autoimmune diseases, and HIV-Aids, however, Elispot can also be applied to other infectious diseases, mainly leishmaniasis, malaria, some viruses, helminths and mycosis usually classified as tropical diseases. The comprehension of the function, concentration and diversity of the immune response in the infectious disease is pointed out as crucial to the development of infection or disease in humans and animals. In this review we will describe the knowledge already obtained using Elispot as a method for accessing the profile of immune response as well as the recent advances in information about host-pathogen interaction in order to better understand the clinical outcome of a group of tropical and neglected diseases.

 Articles related

Jean-Paul Soulillou, Caner Süsal, Bernd Döhler and Gerhard Opelz    

Because of a mutation of the gene allowing the synthesis of the Neu5Gc form of neuraminidic acid, humans lack the Neu5Gc present in other mammals and develop anti-Neu5Gc. However, humans can absorb dietary Neu5Gc and normal colon epithelium displays minu... see more

Revista: Cancers

Tatsuya Ohno, Shin-ei Noda, Kazutoshi Murata, Yuya Yoshimoto, Noriyuki Okonogi, Ken Ando, Tomoaki Tamaki, Shingo Kato, Takashi Hirakawa, Tatsuya Kanuma, Takashi Minegishi, Takashi Nakano and On behalf of the Working Group for Gynecologic Cancer    

A phase I study was performed to determine the recommended dose of carbon ion radiotherapy and 3D image-guided brachytherapy for histologically confirmed stage II (=4 cm), III, or IVA cervical cancer. Dose-limiting toxicities (treatment-related toxicitie... see more

Revista: Cancers

Laith T. Khrais,Abdullah M. Alghamdi    

The paper aims to provide a critical in-depth analysis of Mobile Phone Application's role in enhancing human interaction with E-Retailers, and more specifically, in the Middle East. First, the paper provides an outlook description of the definition and h... see more


Ratu Purwanti,Agnes Rengga Indrati,Nida Suraya,Maya Marinda Montain,Ines Atmosukarto,Neni Nurainy,Ida Parwati    

BACKGROUND: BCG vaccine has been proven to be effective protection against tuberculosis (TB) meningitis and miliary TB. However, for protection against pulmonary TB, the results remains vary widely. Recombinant vaccine consisting of two immunodominant Mt... see more


Anna Meiliana,Andi Wijaya    

BACKGROUND: Immunotherapy, particularly the idea of immune checkpoint blockage is currently draw much attention in cancer treatment. It has been approved as an adjuvant, however, it cannot be a single cancer treatment.CONTENT: The discovery of the basic ... see more